8-KThe WireRoutine
Shareholder Vote · Company Update
Filed Jun 9, 2025 · 1y ago · Accession 0001664710-25-000057
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Keros Therapeutics, Inc.
- Ticker
- KROS
- CIK
- 1664710
- Form type
- 8-K
- Filing date
- Jun 9, 2025
- Report date
- Jun 4, 2025
- Document
- kros-20250604.htm
- Size
- 227 KB